Table 2.
Comparison of IL-6 and IL-8 levels in supernatants obtained from cultures of different types of fibroblasts. (a) Healthy controls: fibroblasts from normal skin of healthy volunteers; (b) psoriatic skin: fibroblasts from lesional skin of psoriatic patients; (c) noninvolved psoriatic skin: fibroblasts from perilesional skin of psoriatic patients.
Evaluated cytokine | Stimulus | Statistical parameters | Type of fibroblast culture | P level | ||
| ||||||
Healthy controls | Psoriatic skin | Noninvolved | ||||
(a) | (b) | psoriatic skin (c) | ||||
| ||||||
IL-6 (pg/mL) | ||||||
Control | range | 560–2265 | 300–3350 | 215–1550 | (a)-(b) P > 0.05 | |
|
(a)–(c) P < 0.05 | |||||
Me | 1444 | 975 | 462 | (b)-(c) P > 0.05 | ||
| ||||||
IL-8 (0.1 μg/mL) | range | 640–3390 | 465–3225 | 270–5465 | (a)-(b)-(c) P > 0.05 | |
| ||||||
Me | 1225 | 967 | 795 | |||
| ||||||
TNF-α (10 ng/mL) | range | 3570–94000 | 2890–32450 | 850–31880 | (a)-(b) P > 0.05 | |
|
(a)–(c) P < 0.05 | |||||
Me | 25890 | 7738 | 4105 | (b)-(c) P > 0.05 | ||
| ||||||
IL-8 (pg/mL) | ||||||
Control | range | 1540–8690 | 435–6080 | 435–6624 | (a)-(b)-(c) - P > 0.05 | |
| ||||||
Me | 2924 | 2803 | 1238 | |||
| ||||||
IL-8 (0.1 μg/mL) | range | 121780–405000 | 222684–416704 | 22412–2879913 | (a)-(b) P > 0.05 | |
|
(a)–(c) P < 0.05 | |||||
Me | 312550 | 344399 | 199391 | (b)-(c) P < 0.05 | ||
| ||||||
TNF-α (10 ng/mL) | range | 126900–540872 | 69866–412728 | 25886–290981 | (a)-(b) P > 0.05 | |
|
(a)–(c) P < 0.05 | |||||
Me | 319359 | 301979 | 123167 | (b)-(c) P < 0.05 |